Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Peg-interferon ADDed to an Ongoing Nucleos(t)Ide Based Treatment in Patients With Chronic Hepatitis B to Induce Decrease of HBs-Antigen (PADD-ON)

This study is currently recruiting participants. (see Contacts and Locations)
Verified November 2015 by Johannes Gutenberg University Mainz
Roche Pharma AG
Information provided by (Responsible Party):
Peter R. Galle, Johannes Gutenberg University Mainz Identifier:
First received: January 31, 2012
Last updated: November 30, 2015
Last verified: November 2015
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2017
  Estimated Primary Completion Date: July 2017 (Final data collection date for primary outcome measure)